Li William W.'s most recent trade in HNI Corp. was a trade of 1,080 Common Stock done at an average price of $50.1 . Disclosure was reported to the exchange on Feb. 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HNI Corp | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 50.14 per share. | 18 Feb 2026 | 1,080 | 14,777 (0%) | 0% | 50.1 | 54,151 | Common Stock |
| HNI Corp | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 50.14 per share. | 18 Feb 2026 | 349 | 13,697 (0%) | 0% | 50.1 | 17,499 | Common Stock |
| Leap Therapeutics Inc | William W. Li | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 94,050 | 94,050 | - | - | Restricted Stock Units | |
| Red Violet Inc | William P. Livek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 3,755 | 18,645 (0%) | 0% | - | Common Stock | |
| Tarsus Pharma Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 81.75 per share. | 15 Dec 2025 | 6,306 | 129,980 | - | 81.8 | 515,516 | Common Stock |
| Tarsus Pharma Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 80.71 per share. | 15 Dec 2025 | 5,680 | 4,766 | - | 80.7 | 458,433 | Common Stock |
| Tarsus Pharma Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 80.80 per share. | 15 Dec 2025 | 5,046 | 136,286 | - | 80.8 | 407,717 | Common Stock |
| Tarsus Pharma Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 81.50 per share. | 15 Dec 2025 | 4,766 | 0 | - | 81.5 | 388,429 | Common Stock |
| Tarsus Pharma Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 82.39 per share. | 15 Dec 2025 | 1,148 | 128,832 | - | 82.4 | 94,584 | Common Stock |
| HNI Corp | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2025 | 13,348 | 13,348 (0%) | 0% | - | Common Stock | |
| Comscore Inc | William P. Livek | Director | Sale of securities on an exchange or to another person at price $ 6.55 per share. | 14 Nov 2025 | 9,900 | 187,473 (0%) | 0% | 6.6 | 64,845 | Common Stock |
| Comscore Inc | William P. Livek | Director | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 12 Nov 2025 | 1,934 | 197,441 (0%) | 0% | 6.9 | 13,248 | Common Stock |
| Comscore Inc | William P. Livek | Director | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 12 Nov 2025 | 68 | 197,373 (0%) | 0% | 7.0 | 475 | Common Stock |
| Leap Therapeutics Inc | William W. Li | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2025 | 74,700 | 74,700 | - | - | Restricted Stock Units | |
| Comscore Inc | William P. Livek | Director | Sale of securities on an exchange or to another person at price $ 7.13 per share. | 10 Nov 2025 | 2,900 | 199,375 (0%) | 0% | 7.1 | 20,677 | Common Stock |
| Comscore Inc | William P. Livek | Director | Sale of securities on an exchange or to another person at price $ 7.57 per share. | 10 Nov 2025 | 2,206 | 203,110 (0%) | 0% | 7.6 | 16,699 | Common Stock |
| Comscore Inc | William P. Livek | Director | Sale of securities on an exchange or to another person at price $ 7.08 per share. | 10 Nov 2025 | 835 | 202,275 (0%) | 0% | 7.1 | 5,912 | Common Stock |
| Spar Grp Inc | William Linnane | President | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 03 Oct 2025 | 173,000 | 190,909 (0%) | 0% | 1.0 | 176,460 | Common Stock, $.01 par value |
| Tarsus Pharma Inc | William J. Link | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Sep 2025 | 2,000 | 141,332 | - | 0 | Common Stock | |
| Steelcase Inc (Class A) | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 2,063 | 60,907 (0%) | 0% | - | Class A Common Stock | |
| Tarsus Pharma Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 57.00 per share. | 08 Sep 2025 | 27,116 | 143,332 | - | 57 | 1,545,612 | Common Stock |
| Comscore Inc | William P. Livek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Zai Lab Ltd (ADR) | William David Lis | Director | Sale of securities on an exchange or to another person at price $ 35.67 per share. | 18 Jun 2025 | 13,814 | 35,106 (0%) | 0% | 35.7 | 492,745 | American Depositary Shares |
| Zai Lab Ltd (ADR) | William David Lis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 48,920 (0%) | 0% | 0 | American Depositary Shares | |
| ServiceTitan Inc (Class A) | William Wei-Liang Hsu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 1,891 | 1,891 | - | 0 | Class A Common Stock | |
| Comscore Inc | William P. Livek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2025 | 10,739 | 205,316 (0%) | 0% | 0 | Common Stock | |
| Comscore Inc | William P. Livek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2025 | 10,739 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 4,540 | 4,540 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 170,448 | - | - | Common Stock | |
| Tarsus Pharma Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 2,954 | 2,954 | - | - | Restricted Stock Units | |
| Steelcase Inc (Class A) | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 3,224 | 58,844 (0%) | 0% | - | Class A Common Stock | |
| Intuitive Machines Inc (Class A) | William Liquori | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 18,383 | 81,248 | - | 0 | Class A Common Stock | |
| RxSight Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 10,752 | 37,855 | - | - | Common Stock | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 7,374 | 550,641 | - | 0 | Common Stock | |
| Eastern Bankshares Inc | Linda Marie Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 4,172 | 8,868 | - | 0 | Common Stock | |
| Ampco-Pittsburgh Corp | William K. Lieberman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 12,728 | 50,912 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2025 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.00 per share. | 22 Apr 2025 | 10,000 | 58,723 (0%) | 0% | 24 | 240,000 | Common Stock |
| Steelcase Inc (Class A) | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 3,000 | 55,620 (0%) | 0% | - | Class A Common Stock | |
| Red Violet Inc | William P. Livek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,980 | 14,890 (0%) | 0% | - | Common Stock | |
| RE/MAX Holdings Inc (Class A) | William Grady Ligon | CHIEF INFORMATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 41,386 | 190,500 (1%) | 0% | 0 | Class A Common Stock | |
| RE/MAX Holdings Inc (Class A) | William Grady Ligon | CHIEF INFORMATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 41,386 | 231,886 (1%) | 0% | 0 | Class A Common Stock | |
| RE/MAX Holdings Inc (Class A) | William Grady Ligon | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.88 per share. | 01 Mar 2025 | 5,274 | 226,612 (1%) | 0% | 8.9 | 46,833 | Class A Common Stock |
| Zai Lab Ltd (ADR) | William Lis David | Director | Sale of securities on an exchange or to another person at price $ 32.98 per share. | 28 Feb 2025 | 15,000 | 38,089 (0%) | 0% | 33.0 | 494,700 | American Depositary Shares |
| RE/MAX Holdings Inc (Class A) | William Grady Ligon | CHIEF INFORMATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 13,190 | 153,018 (0%) | 0% | 0 | Class A Common Stock | |
| RE/MAX Holdings Inc (Class A) | William Grady Ligon | CHIEF INFORMATION OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.93 per share. | 25 Feb 2025 | 3,272 | 149,746 (0%) | 0% | 8.9 | 29,219 | Class A Common Stock |
| Bruker Corp | William A. Linton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 3,298 | 48,723 (0%) | 0% | 0 | Common Stock | |
| Steelcase Inc (Class A) | K. Linda Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 2,450 | 52,620 (0%) | 0% | - | Class A Common Stock | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.12 per share. | 22 Nov 2024 | 10,000 | 45,425 (0%) | 0% | 19.1 | 191,200 | Common Stock |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Red Violet Inc | William P. Livek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 3,760 | 12,910 (0%) | 0% | - | Common Stock | |
| Leap Therapeutics Inc | William W. Li | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Steelcase Inc (Class A) | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 2,446 | 50,170 (0%) | 0% | - | Class A Common Stock | |
| Tarsus Pharma Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2024 | 74,892 | 35,000 | - | 0 | Common Stock | |
| Tarsus Pharma Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 26.01 per share. | 12 Aug 2024 | 29,979 | 5,021 | - | 26.0 | 779,754 | Common Stock |
| Tarsus Pharma Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2024 | 27,116 | 167,098 | - | 0 | Common Stock | |
| Tarsus Pharma Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 12 Aug 2024 | 10,446 | 10,446 | - | 0 | Common Stock | |
| Tarsus Pharma Inc | William J. Link | Director | Sale of securities on an exchange or to another person at price $ 26.53 per share. | 12 Aug 2024 | 5,021 | 0 | - | 26.5 | 133,207 | Common Stock |
| Comscore Inc | William P. Livek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 10,739 | 10,739 | - | - | Restricted Stock Units | |
| Zai Lab Ltd (ADR) | William Lis | Director | Sale of securities on an exchange or to another person at price $ 17.31 per share. | 01 Jul 2024 | 10,297 | 53,189 (0%) | 0% | 17.3 | 178,281 | American Depositary Shares |
| Zai Lab Ltd (ADR) | William Lis | Director | Sale of securities on an exchange or to another person at price $ 18.04 per share. | 01 Jul 2024 | 100 | 53,089 (0%) | 0% | 18.0 | 1,804 | American Depositary Shares |
| Tarsus Pharma Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | William J. Link | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 139,982 | - | - | Common Stock | |
| Zai Lab Ltd (ADR) | William Lis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 21,253 | 63,486 (0%) | 0% | 0 | American Depositary Shares | |
| Tarsus Pharma Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Comscore Inc | William P. Livek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 8,415 | 0 | - | - | Restricted Stock Units | |
| Comscore Inc | William P. Livek | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 8,415 | 194,577 (0%) | 0% | 0 | Common Stock | |
| Knightscope Inc (Class A) | William Santana Li | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 4,000,000 | 4,000,000 | - | - | Stock Option (Right to Buy) | |
| Steelcase Inc (Class A) | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 2,575 | 47,724 (0%) | 0% | - | Class A Common Stock | |
| Intuitive Machines Inc (Class A) | William Liquori | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 44,544 | 62,865 | - | 0 | Class A Common Stock | |
| RxSight Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 2,554 | 27,103 | - | - | Common Stock | |
| Knightscope Inc (Class A) | William Santana Li | Director, Chairman, CEO & President | Purchase of securities on an exchange or from another person at price $ 0.32 per share. | 05 Jun 2024 | 83,333 | 83,333 | - | 0.3 | 26,350 | Class A Common Stock |
| Orchestra BioMed Holdings Inc | William Reed Little | See Remarks | 30 May 2024 | 4,000 | 307,859 | - | 7 | 28,000 | Common Stock, par value $0.0001 per share ("Common Stock") | |
| Ampco-Pittsburgh Corp | William K. Lieberman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 12,728 | 38,184 (0%) | 0% | 0 | Common Stock | |
| Eastern Bankshares Inc | Linda Marie Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 4,696 | 4,696 | - | 0 | Common Stock | |
| Orchestra BioMed Holdings Inc | William Reed Little | See Remarks | 08 May 2024 | 53,333 | 303,859 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | ||
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 22,000 | 543,267 | - | 0 | Common Stock | |
| Steelcase Inc (Class A) | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 2,488 | 45,149 (0%) | 0% | - | Class A Common Stock | |
| RE/MAX Holdings Inc (Class A) | William Grady Ligon | CHIEF INFORMATION OFFICER | 01 Mar 2024 | 52,500 | 107,085 (0%) | 0% | 0 | Class A Common Stock | ||
| RE/MAX Holdings Inc (Class A) | William Grady Ligon | CHIEF INFORMATION OFFICER | 01 Mar 2024 | 35,000 | 142,085 (0%) | 0% | 0 | Class A Common Stock | ||
| RE/MAX Holdings Inc (Class A) | William Grady Ligon | CHIEF INFORMATION OFFICER | 01 Mar 2024 | 2,257 | 139,828 (0%) | 0% | 0 | Class A Common Stock | ||
| RE/MAX Holdings Inc (Class A) | William Ligon Grady | CHIEF INFORMATION OFFICER | 23 Feb 2024 | 8,926 | 56,995 (0%) | 0% | 0 | Class A Common Stock | ||
| RE/MAX Holdings Inc (Class A) | Ligon Grady William | CHIEF INFORMATION OFFICER | 23 Feb 2024 | 2,410 | 54,585 (0%) | 0% | 0 | Class A Common Stock | ||
| RxSight Inc | Link J. William | Director | Sale of securities on an exchange or to another person at price $ 49.54 per share. | 01 Feb 2024 | 20,598 | 31,900 | - | 49.5 | 1,020,456 | Common Stock |
| RxSight Inc | Link J. William | Director | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 01 Feb 2024 | 7,652 | 24,248 | - | 50.0 | 382,664 | Common Stock |
| RxSight Inc | William J. Link | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2024 | 3,000 | 21,248 | - | 0 | Common Stock | |
| Leap Therapeutics Inc | Li William W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Red Violet Inc | William P. Livek | Director | Purchase of securities on an exchange or from another person at price $ 18.40 per share. | 11 Jan 2024 | 4,898 | 9,148 (0%) | 0% | 18.4 | 90,138 | Common Stock |
| Red Violet Inc | Livek P. William | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 11 Jan 2024 | 2 | 9,150 (0%) | 0% | 18 | 36 | Common Stock |
| Red Violet Inc | P. Livek William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 4,150 | 4,250 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | William A. Linton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 2,377 | 35,425 (0%) | 0% | 0 | Common Stock | |
| Steelcase Inc (Class A) | K. Williams Linda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2023 | 2,573 | 42,661 (0%) | 0% | - | Class A Common Stock | |
| Bruker Corp | William A. Linton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.07 per share. | 05 Dec 2023 | 10,000 | 33,048 (0%) | 0% | 19.1 | 190,700 | Common Stock |
| Bruker Corp | Linton William A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Steelcase Inc (Class A) | Linda K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2023 | 3,803 | 40,088 (0%) | 0% | - | Class A Common Stock | |
| Leap Therapeutics Inc | William W. Li | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Creative Realities Inc | William Lindsey Logan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 21 Aug 2023 | 12,500 | 14,523 (0%) | 0% | 2 | 25,000 | Common Stock |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 17 Aug 2023 | 694,124 | 0 | - | 0 | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 17 Aug 2023 | 21,248 | 52,498 | - | 0 | Common Stock |